AAAAAA

   
Results: 1-8 |
Results: 8
Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group
Authors: Pectasides, D Aravantinos, G Kalofonos, H Kiamouris, C Bafaloukos, D Xiros, N Nicolaides, C Visvikis, A Dimopoulos, MA
Citation: D. Pectasides et al., Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 12(10), 2001, pp. 1417-1422
Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer
Authors: Razis, E Dimopoulus, AM Bafaloukos, D Papadimitriou, C Kalogera-Fountzila, A Kalofonos, H Briassoulis, E Samantas, E Keramopoulos, A Pavlidis, N Kosmidis, P Fountzilas, G
Citation: E. Razis et al., Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer, CANCER INV, 19(2), 2001, pp. 137-144
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer
Authors: Fountzilas, G Papadimitriou, C Aravantinos, G Nicolaides, C Stathopoulos, G Bafaloukos, D Kalofonos, H Ekonomopoulos, T Skarlos, D Pavlidis, N Dimopoulos, AM
Citation: G. Fountzilas et al., Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer, ONCOL-BASEL, 60(3), 2001, pp. 214-220
Phase II study of pegylated liposomal doxorubicin: Inactive in recurrent small-cell lung cancer - A Hellenic Cooperative Oncology Group Study
Authors: Samantas, E Kalofonos, H Linardou, H Nicolaides, C Mylonakis, N Fountzilas, G Kosmidis, P Skarlos, D
Citation: E. Samantas et al., Phase II study of pegylated liposomal doxorubicin: Inactive in recurrent small-cell lung cancer - A Hellenic Cooperative Oncology Group Study, ANN ONCOL, 11(11), 2000, pp. 1395-1397
Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: A Hellenic cooperative oncology group phase II study
Authors: Fountzilas, G Nicolaides, C Bafaloukos, D Kalogera-Fountzila, A Kalofonos, H Samelis, G Aravantinos, G Pavlidis, N
Citation: G. Fountzilas et al., Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: A Hellenic cooperative oncology group phase II study, CANCER INV, 18(6), 2000, pp. 503-509
Carboplatin plus paclitaxel in unknown primary carcinoma: A phase II Hellenic Cooperative Oncology Group study
Authors: Briasoulis, E Kalofonos, H Bafaloukos, D Samantas, E Fountzilas, G Xiros, N Skarlos, D Christodoulou, C Kosmidis, F Pavlidis, N
Citation: E. Briasoulis et al., Carboplatin plus paclitaxel in unknown primary carcinoma: A phase II Hellenic Cooperative Oncology Group study, J CL ONCOL, 18(17), 2000, pp. 3101-3107
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group
Authors: Fountzilas, G Stathopoulos, G Nicolaides, C Kalogera-Fountzila, A Kalofonos, H Nikolaou, A Bacoyiannis, C Samantas, E Papadimitriou, C Kosmidis, P Daniilidis, J Pavlidis, N
Citation: G. Fountzilas et al., Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 10(4), 1999, pp. 475-478
Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer
Authors: Samantas, E Skarlos, DV Pectasides, D Nicolaides, P Kalofonos, H Mylonakis, N Vardoulakis, T Kosmidis, P Pavlidis, N Fountzilas, G
Citation: E. Samantas et al., Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer, LUNG CANC, 23(2), 1999, pp. 159-168
Risultati: 1-8 |